Bellevue Group AG VRTX Holdings History

Number of Shares
413,071.00
Current Holdings Value*
$200.27 Mil
% of Portfolio
4.49%
Total Estimate Gain
$338.35 Mil
% of Total Estimate Gain
76.23%

Bellevue Group AG's Vertex Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Bellevue Group AG held 413,071.00 shares of Vertex Pharmaceuticals Inc(VRTX), totaling $200.27 Mil. This investment constitutes 4.49% of their stock portfolio, and Bellevue Group AG now holds 0.16% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.

The initial trade took place in 2018Q2. And since then Bellevue Group AG has made 10 purchases of VRTX, at an average price of $192.00, for a total of 2.31 Mil shares. In addition, there have been 18 sales at an average price of $311.94 for 1.90 Mil shares. Based on historical transaction data and VRTX's current price of $459.81, Bellevue Group AG's estimated gain on his VRTX holdings is $338.35 Mil, reflecting a 76.23% gain to date.

Bellevue Group AG VRTX ($459.81) Holding Chart

Bellevue Group AG VRTX ($459.81) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1